Forte Biosciences (FBRX) Other Non Operating Income (2016 - 2026)
Forte Biosciences' Other Non Operating Income came in at $1.47 million for Q2 2026, up 343.9% from $330,000 a year earlier and up 116.7% from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) Other Non Operating Income (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Forte Biosciences reported Other Non Operating Income of $947,000; for FY2025, it was -$396,000.
- Going back by year, Other Non Operating Income was -$190,000 in FY2024, -$114,000 in FY2023, -$145,000 in FY2022 and -$222,000 in FY2021.
- The Q2 2026 figure represents the highest quarterly Other Non Operating Income in data going back to Q1 2016.
- Year-over-year, Other Non Operating Income increased in five of the last six quarters, with growth averaging 100.7%.
- The fastest year-over-year change in Other Non Operating Income over five years came in Q2 2026 (growth of 343.9%), and the weakest in Q3 2024 (a decline of 9.2%).
- Business Quant data shows FBRX's Other Non Operating Income at $676,000 (Q1 2026), -$1.9 million (Q4 2025) and $701,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Mar 31, 2026 | 676,000.00 |
| Dec 31, 2025 | -1.90 Mn |
| Sep 30, 2025 | 701,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Dec 31, 2024 | -1.12 Mn |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 307,000.00 |
| Mar 31, 2024 | 384,000.00 |
| Dec 31, 2023 | -615,000.00 |
| Sep 30, 2023 | 261,000.00 |
| Jun 30, 2023 | 138,000.00 |
| Mar 31, 2023 | 102,000.00 |
| Dec 31, 2022 | -100,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -53,000.00 |
| Dec 31, 2021 | -42,000.00 |
| Sep 30, 2021 | -52,000.00 |
API Access
Forte Biosciences Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();